India underlines 'robust, balanced' IP regime at WIPO
This article was originally published in Scrip
Executive Summary
A senior Indian government minister has underlined to a meeting of the World Intellectual Property Organization that recent pharma-related patent decisions are not the whims of rogue officials or judges but are fully in line with India’s industry and development policies. The clear message to the world’s drug companies is that India will use whatever ‘flexibility’ exists in international intellectual property agreements to help reach its aspirations.